Cypherpunk Technologies Inc.
CYPH Healthcare Biotechnology
In the quarter to June 2026, EPS grew 152.5% and free cash flow grew 15.5%, each against the same quarter a year earlier.
Follow CYPH
Cypherpunk Technologies Inc. (CYPH) Altman Z-score
Cypherpunk Technologies Inc.'s Altman Z-score for fiscal 2021 is 13.46, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2021 | 13.46 | 9.54 |
| FY2020 | 3.92 | — |
How fiscal 2021’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.91 | — | 1.09 | |
| Retained earnings / total assets | (2.24) | — | −3.13 | |
| EBIT / total assets | (0.35) | — | −1.16 | |
| Market value of equity / total liabilities | 27.74 | — | 16.64 | |
| Sales / total assets | 0.01 | — | 0.01 | |
| Altman Z-score | Safe zone | 13.46 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 7.60 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| CYPH Cypherpunk Technologies Inc. | 13.5× |
| ARCT Arcturus Therapeutics Holdings Inc. compare | −0.6× |
| ENTA Enanta Pharmaceuticals, Inc. compare | −1.4× |
| CCCC C4 Therapeutics, Inc. compare | −2.2× |
| OBIO Orchestra BioMed Holdings, Inc. compare | −2.7× |
| IRD Opus Genetics, Inc. compare | −4.3× |
| AGEN Agenus Inc. compare | −14.2× |
| TTRX Turn Therapeutics Inc. compare | — |
| RLMD Relmada Therapeutics, Inc. compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets